According to market researcher Mintel, 28% of all facial cleansing launches in the last year have had a sensitive skin claim.
This is due to growing numbers of adult consumers believing they have sensitive skin, with a recent study showing 38% of Europeans consider themselves to have sensitive skin which is reflected with this increase in launches with this claim.
With this in mind, Croda has released new data showing Cromollient SCE has the ability to mitigate skin irritation caused by surfactants and provides a soft skin feel and is suitable for clear systems.
“Products designed for sensitive skin are very important in the baby and child personal care market due to the delicate nature of their young skin,” says the ingredients supplier. “But sensitive skin is not just a problem for babies and children.”
“The general mild and gentle product trend is on the rise with increasing numbers of products claimed to be designed for sensitive skin.”
An in-vivo study was carried out showing Cromollient SCE does not cause any skin irritation and can reduce the irritation of SLS on the skin from only a 1% usage level.
A second study looked at the irritation reduction potential of post-adding Cromollient SCE to three commercial body washes at a 5% usage level. In the in-vitro study, skin irritation was decreased by a minimum of 20% with all formulations containing Cromollient SCE.
It has been an eventful time for Croda, as it has also been awarded first place in the innovation segment, second in the chemical sector category and eighth place overall in the 2014 Britain’s Most Admired Companies Awards.
“To be named Britain’s most Innovative Company is a fantastic accolade and we are hugely proud to collect this award,” says Steve Foots, Chief Executive of Croda.
“Innovation runs through every part of our business and for this to be recognised by industry peers, and the investment community, is testament to the dedication and hard work of our employees across the globe.”